Annual grant for one faculty member to explore an industry related to their area of research with the goal of discovering near-term commercialization opportunities. Over a 12-month period, the faculty member receives a $30,000+ grant to lead a team consisting of a graduate student, undergraduate researchers / market analysts, and paired with an Industry Guide to support their efforts.

The Entrepreneurship Minor teaches students how to become innovative leaders and make meaningful impact in their communities. Our curriculum requires students to learn fundamental skills in ideation creation, business plans, marketing, pitching, and product development. In summary, students learn how to plan and launch new projects, products and startups.

The Office of Technology Commercialization has an expert team dedicated to helping interested parties find the best UT technologies for their specific needs. Through utilization of a powerful web-based search tool, or connecting one-on-one with a team member, we can provide a tailored list of available UT intellectual property. Our team works with potential partners to transfer university technology or discoveries to the marketplace for the benefit of society.

Genesis is a student-alumni partnership with over $1.8 million to distribute to student-founded companies through non-dilutive grants, along with the time and talent of our diverse and entrepreneurial leadership team. Genesis has helped founders develop their businesses, build their products, generate their first revenue, recruit cofounders and early employees, brainstorm ideas, and raise future funding from top investors. All students can apply for funding and mentorship.

The UT System Board of Regents Rule 90101: Intellectual Property provides guidance on timely and efficient processes to manage intellectual property. These fundamental principles are intended to be adaptable to the highly varied circumstances that characterize the private sector and the portfolio of research at UT System institutions.

Texas Venture Labs works campus-wide across disciplines to transform graduate students into entrepreneurs and business leaders, take their innovations to market, and accelerate startups in our ecosystem. We do this through our Practicum course and Fellows program that provide experiential learning for grad students, our Investment Competition, and our Accelerator. Let us help you build your skills while launching your dreams.

The Office of Technology Commercialization (OTC) is the only organization on campus authorized to manage university-owned IP (trademarks excepted). The OTC works with researchers to define the technology, assess its development stage, strategize potentially valuable patent claims, and as necessary, file patents to protect the IP in advance of publication. The OTC also supports technologies that are not patentable, such as software and copyrighted works that may be commercialized via license.

The Office of Technology Commercialization helps UT researchers monetize software and creative content they develop while at the university. The Office of Technology Commercialization can help researchers find the optimal license type and distribution strategy for such work, which includes open sourcing. The Office of Technology Commercialization also helps with finding commercialization partners, negotiating licenses, and supporting startups.

A 9-week summer accelerator program that picks the most promising emerging UT startups (undergrad, grad, and faculty teams) and helps them confront their next market-driven milestone. In its 13th year, alumni companies have collectively raised $100M and generated over $400M in valuation.

The Texas Global Health Security Innovation Consortium (TEXGHS) connects academic, public- and private-sector partners to support companies working towards pandemic preparedness and response in Texas. TEXGHS is developing a health security innovation ecosystem that supports innovators and innovations fighting COVID-19 and future pandemics. UT Austin entrepreneurs should contact TEXGHS when they are seeking to commercialize infectious disease-related innovations at any stage of development.